The Immune System
Adaptive Immunity
Specific Resistance: Immunity
 It is mediated by the combined actions of both T and B lymphocytes
 “THIRD LINE OF DEFENSE”
 Specific immunity differs from nonspecific defense mechanisms with respect
to:
 Unresponsiveness to self - recognizes self cells vs. non-self cells/compounds
 Memory - second and subsequent encounters produce an even more vigorous
response than the first encounter with the same foreign cell/compound
 Inducibility - the presence of specific, identifiable pathogens will induce/stimulate
 Clonality - Upon activation, the cells involved in specific immunity reproduce
identical “offspring”
 Specificity - made against particular, recognizable, foreign molecules, cells, etc.
response is directed against one and only one of these items
The Role of T and B Cells in Specific
Immunity
 T-cells mature in the thymus;
 responsible for the cell-mediated immune
response
 effective against fungi, viruses, parasites,
cancer, and tissue transplants
 Killer T-cells
 directly attack antigens = cytotoxic T-cells
 Helper T-cells
 co-stimulate T- and B-cells
 B-cells mature in the bone marrow
 effective against extracellular pathogens such as
bacteria
 antibody-mediated immune response
 plasma cells (activated B cells) that form
antibodies and actively secrete them
The Lymphatic System
 The lymphatic system drains lymph from all areas of the body
and sends it back towards the heart to be returned to the blood
circulatory system.
 Once mature, the T and B cells migrate into the secondary
lymphoid organs and lymphoid tissues such as lymph nodes, the
spleen, tonsils, MALT (mucosa-associated lymphoid tissue),etc.
 As the lymph moves through the lymphatic system, it is under
constant surveillance for the presence of pathogens by the
various cells of adaptive immunity
Blood
capillary
From heart
Tissue cell
Intercellular
fluid
Lymph
to heart
via lymphatic
vessels
Gap in wall
Valve
Lymphatic capillary
To heart
Afferent
lymphatic vessel
Medulla
Vein
Artery
Efferent
lymphatic
vessel
Capsule
Primary follicle
Lymphatic nodule
Valve
(prevents backflow)
Cortex
Tonsils
Cervical lymph node
Lymphatic ducts
Thymus gland
Axillary lymph
node
Heart
Breast lymphatics
Spleen
Abdominal
lymph node
Intestines
Peyer's patches in
intestinal wall
Part of mucosa-
associated lymphoid
tissue (MALT)
Appendix
Red bone
marrow
Inguinal lymph
node
Lymphatic
vessel
What is an Antigen?
 Molecules or bits of foreign material
 entire microbes, parts of microbes, bacterial toxins, pollen,
transplanted organs, incompatible blood cells
 An antigen has:
 Immunogenicity = the ability to provoke an immune response by
stimulating the production of specific antibodies &/or specific T-
cells
 Reactivity = the ability to react to the cells or to the antibodies it
caused to be formed
 If antigens get past the body’s nonspecific defenses where do they go
to next?
 They may:
 Enter the bloodstream to be deposited in the spleen
 Penetrate the skin & end up in the lymph nodes
 Penetrate mucous membrane & lodge in the associated lymphoid tissue
The Chemical Nature of
Antigens/Epitopes
 Antigens are generally large, complex molecules, usually
proteins, though some lipids and carbohydrates can be
antigens
 If they have simple repeating subunits they are not usually
antigenic
 (I.e. plastics or metals in joint replacements)
 The small part of an antigen that actually elicits the immune response is called
the epitope
 It is also referred to as an antigenic determinant because it is the portion of
the molecule that allows your immune system to determine that the molecule
itself is an antigen.
Epitopes
(antigenic
determinants)
Cytoplasmic
membrane
Cytoplasm
Antigen
Epitopes (antigenic determinants)
Nucleus
Figure 3a Antigens, molecules that provoke a specific
immune response.
Extracellular
microbes
Exogenous
antigens
Endogenous
antigens
Intracellular
virus
Virally
infected
cell
Autoantigens
(normal cell antigens)
Normal
(uninfected)
cell
Exogenous antigens Endogenous antigens Autoantigens
Figure 3b-d Antigens, molecules that provoke a specific
immune response.
An antibody interacting with the epitope
on an antigen
Sources of Antigens
 Antigens can originate exogenously, as parts of microbial
cells’ structure (i.e. cell walls, flagella, pili, plasma
membrane), or as chemicals secreted/released by a
microbe (i.e. toxins)
 Some antigens are referred to as being endogenous
because their source is a microbe that reproduces inside
the body’s own cells. Such microbes include viruses,
protozoa, fungi and some bacteria.
 How does the immune system detect endogenous antigens?
 The affected body cells must incorporate/add the antigen to the plasma
membrane of that body cell so that it can be ‘seen’ or detected by cells of
adaptive immunity
 Finally, some antigens are referred to as being autoantigens because they are
molecules belonging to ‘self’. Normally, the immune system learns tolerance
to these cells and ‘ignores’ them
Diversity of Antigen Receptors
 The immune system can recognize and respond to a billion different epitopes
-- even artificially made molecules
 An explanation for the great diversity of receptors is that this diversity is
produced by the genetic recombination of a few hundred small gene
segments
 Each B or T-cell, by the time it has matured, has its own unique set of gene
segments (produced through somatic recombination) that codes for its own
unique antigen receptor, located in the B or T-cell’s plasma membrane
 Therefore, we have an enormously diverse population of immune cells ready to
respond to foreign antigens
Major Histocompatibility Complex (MHC)
Antigens
 They are a family of membrane proteins
 All of our cells have unique surface markers (1000s of molecules)
 These integral membrane proteins are called HLA (for human leukocyte
antigen) antigens, or MHC-antigens/markers
 While these proteins are recognized as ‘self’ in OUR bodies, in another person,
with different MHC-markers, these same molecules would stimulate a specific
immune response
 Hence, they are usually referred to as MHC-antigens
 Reference to them as ‘markers’ in these notes is done to avoid confusion with
use of the word ‘antigen’ as a reference to foreign molecules (i.e. from
bacteria, virus, etc.)
 The MHC markers allow our bodies to identify ‘self’ versus ‘non-self’ based on
the precise nature of the MHC molecules on the cell surfaces
 MHC-I markers are built into the cell membrane of all cells except red blood
cells
 Therefore, they are often referred to as being present on all nucleated cells in
our bodies
 MHC-II markers are seen only on the membrane of specialized antigen-
presenting cells (such as macrophages, B cells, and thymus cells)
 When antigen-presenting cells (APCs) (macrophages or B cells) ingest foreign
proteins through phagocytosis, they will display them as part of (i.e. attached
to) their MHC-II markers
 This series of proteins is coded for genetically and involves a large number of
alleles
 Only identical twins carry the same set of MHCs
 MHC markers are important in tissue transplantation since they identify ‘self’
versus ‘foreign’ tissue types to the recipient’s immune system
 MHC-I marker molecules also help cells display antigens from intracellular
pathogens (i.e. endogenous antigens)
Polypeptide
is catabolized.
Epitopes
MHC I protein
in membrane
of endoplasmic
reticulum
Lumen of
endoplasmic
reticulum
Epitopes are loaded onto complementary MHC I
proteins in the ER.
MHC I protein–
epitope complex
Golgi bodies package MHC I protein–epitope
complexes into vesicles.
MHC I protein–
epitope
complexes on
cell surface
Cytoplasmic
membrane
MHC I protein–epitope complexes are displayed
on cytoplasmic membranes of all nucleated cells.
5
4
3
2
1
Vesicles fuse with cytoplasmic membrane.
Figure 12 The processing of endogenous antigens.
Phagocytosis
by APC
Exogenous
pathogen
with antigens
MHC II protein in
membrane of vesicle
Epitopes in
phagolysosome
MHC II protein–
epitope complex
Vesicles fuse and epitopes bind to
complementary MHC II molecules.
Vesicle fuses with cytoplasmic membrane.
MHC II protein–
epitope
complexes on
cell surface
Cytoplasmic
membrane
MHC II protein–epitope complexes are displayed
on cytoplasmic membranes of antigen-
presenting cell.
1
2
3
4
Figure 13 The processing of exogenous antigens.
 MHC-II antigens then bind to receptors on helper T cells
 The helper T cells are now activated by this interaction and will go on to
activate cytotoxic T cells and B cells (the latter of which will produce
antibodies to the foreign protein that was originally displayed)
Cell-Mediated Immunity
 Begins with the activation of a T-cell by a specific antigen; recognition of that
antigen is the FIRST signal in the T-cell activation process
 The T-cell will bind to the recognized antigen and only then will receive a
SECOND signal; this signal is the co-stimulation of the T-cell by chemicals such
as cytokines or by the plasma membrane molecules on both the T-cell and the
antigen-presenting cell
 Once the T-cell has received TWO signals it is activated
 The T-cell then proliferates (divides) and differentiates into identical effector
cells (a clone) that are all capable of recognizing the SAME antigen
 The activation, proliferation and differentiation of the various types of T-cells
occurs in the secondary lymphatic organs such as the lymph nodes
 The result is the production of a population of T-cells capable of an immune
attack against THAT antigen
 The elimination of the intruder occurs via a direct attack on the intruder by
the T-cells
Types of T-Cells
 Helper T-cells; TH; also called CD4+
cells because they display CD4 protein
 Cytotoxic T-cells; TC; also called CD8+
cells because they display CD8 protein
 Memory T-cells; of both of above kinds; long-term ‘memory’ of encountered
antigens that permits rapid, strong second response to that antigen
Helper T-cells
 Recognize antigen fragments bound to the MHC-II molecules in the plasma
membranes of APCs
 The MCH-II molecules also bind to and ‘activate’ the TH cells
 Co-stimulation occurs and leads to the TH-cell’s production of cytokines such as
interleukin-2 (which stimulates further T-cell differentiation and further release
of IL-2)
 Activated T-cell proliferates & differentiates into a population (clone) of active
TH cells and long-lived memory TH cells
Figure 14 Activation of a clone of cytotoxic T (Tc) cells.
Antigen presentation
MHC II
Epitope
TCR
Th
cell
Th differentiation
Th1 cell
IL-2R
IL-2
IL-2R
IL-12
DC
IL-2
Active
Tc cells
MHC I
Inactive
Tc cell
IL-2 receptor
(IL-2R)
Clonal expansion
Memory
T cell
Self-stimulation
IL-2
IL-2
Dendritic cell
MHC I
CD8 Epitope
TCR
Tc cell
Immunological synapse
Active Tc cells
1
2
3
4
 The overall function of TH cells is to co-stimulate all other lymphocytes,
including natural killer cells by:
 Secretion of cytokines (i.e. interleukin-2)
 The use of cytokines for the co-stimulation of more TH cells
 The co-stimulation role of cytokines is an autocrine function in that the
cytokine co-stimulates the TH cell that secreted it, causing the TH cell to
proliferate and secrete even more cytokines such as interleukin (this is a
positive feedback effect that stimulates the formation of many more active
helper T-cells)
Cytotoxic T-cells
 Known as T8 or Tc or killer T-cells
 Recognize antigen fragments that are bound to MHC-I molecules; these would
be found on:
 Cells infected with a virus
 Tumor cells
 Tissue transplants of non-matching tissue type
 Co-stimulation of cytotoxic T-cells is required for them to be active, and this
is accomplished by the presence of cytokine chemicals that are produced by
the helper T-cell population
 Maximal activation of cytotoxic T-cells occurs when an antigen is presented in
association with BOTH MHC-I and MHC-II molecules
 The TC cell then proliferates & differentiates into a population (clone) of active
Tc cells and memory Tc cells
 This step occurs in the secondary lymphatic organs such as the lymph nodes
Memory T-cells
 Memory T-cells are T-cells from a clone that did not turn into either active TH
or active TC cells during a cell-mediated response
 These cells are available for swift response if a second exposure to the same
antigen should occur
 These cells ‘remember’ which antigen to react to, therefore are termed
‘memory’ T-cells
Elimination of Invaders
 Activated TC cells migrate to the site of
infection or tumor formation
 These cells recognize the specific antigen,
attach to it & attack
 They ultimately kill the cell to which the
antigen is bound by:
 1. Secretion of granules containing perforin that punches holes in the
target-cell which will then permit the entry of a cytotoxin known as
granzyme whose action is to induce apoptosis in the target cell
 2. Secretion of a chemical called lymphotoxin that activates enzymes in the
target-cell, causing its DNA to fragment; target cell dies
 3. Secretion of gamma-interferon to activate phagocytic cells, which engulf
target cell and digest it
 Thus, foreign cells, cells infected with viruses or cells that have turned
cancerous, will be killed
Active
cytotoxic T
(Tc) cell
TCR
Viral epitope
MHC I
protein
Virally
infected cell
Intracellular
virus
CD8
Figure 15a. A cell-mediated immune response.
44
Tc cell
Perforin Granzyme
Perforin
complex (pore)
Granzymes activate
apoptotic enzymes
Inactive
apoptotic
enzymes Active enzymes
induce apoptosis
Virally infected cell
Tc cell
CD95L
CD95
Enzymatic
portion of CD95
becomes active
Inactive
apoptotic
enzymes Active enzymes
induceapoptosis
Virally infected cell
Figure 15b-c A cell-mediated immune response.
Immunological Surveillance
 A cancerous cell displays weird/unusual surface antigens (tumor antigens) that
are rarely, if ever, found on normal cells
 Surveillance = ability for the immune system to find, recognize & destroy
those cells that are displaying tumor antigens
 Immunological surveillance is performed by cytotoxic T-cells, macrophages &
natural killer cells
 It is especially effective at finding tumors that are caused by viruses
 Transplant patients taking immunosuppressive drugs are at the greatest risk of
contracting viral-induced cancers
Graft Rejection
 After a tissue or organ transplant, the immune system may produce both a
cell-mediated and an antibody-mediated immune response
 This response constitutes graft rejection
 Having a close match of MHC antigens will result in a weaker graft rejection
response
 The chance of a graft rejection can also be reduced by the use of
immunosuppressive drugs (such as cyclosporine); these drugs Inhibit the
secretion of interleukin-2 by helper T-cells
 However, the drugs have little effect on B cells so the patient maintains some
resistance
Antibody-Mediated Immunity
 Our bodies contain millions of different B cells that can recognize different
antigens and respond to them
 B cells sit still and let antigens be brought to them
 The B cells are specifically located in the lymph nodes, the spleen or in
Peyer’s Patches (in the GI system)
 Once activated, B-cells differentiate into plasma cells that actively secrete
antibodies
 The antibodies circulate in the lymph and the blood
 The antibody combines with an epitope on the antigen, similarly to a key
fitting a specific lock
 B cell receptors bind to an antigen – the
response will be even more intense if the
antigen is already on an APC
 A helper T-cell costimulates the B cell
 The stimulated B-cell then undergoes rapid
cell division and differentiation to
produce:
 1. Long-lived memory cells
 2. A clone of plasma cells (which will actively secrete antibodies against the
antigen)
 The plasma cells will produce antibodies at a rate of 2000 Ab molecules/sec for
4-5 days
 The plasma cells secrete only one kind of Ab ( the one that is specific to the
original Ag)
 The Ab enters the blood/lymph circulation to attack the antigen
Repertoire of Th cells (CD4 cells)
CD4
TCRs
APC presents
antigen to Th cells
for Th activation
and cloning.
APC
Th cell
TCR
Epitope
MHC II
CD4
CD28
CD80
(or
CD86)
APC
Th cell clones
Th cell differentiates
into Th2 cell.
CCR3
CCR4
Th2 cell
IL-4
MHC II
proteins
Repertoire of B cells
Th2 cell TCR
Epitope
MHC II
CD40
CD40L
CD4
Th2 cell
activates B cell.
Clone of
plasma cells
Antibodies
Memory B cells
Th2 cell
B cell
1
2
3
4
IL-4
Figure 18 A T-dependent antibody immune response.
Antibody Structure
 Antibodies are glycoproteins that are also called immunoglobulins
 They contain 4 polypeptide chains -- 2 heavy & 2 light chains
 There is a hinged midregion that lets the Ab assume either a T or a Y shape
 The tips are the variable regions – these form the Ag-binding sites
 The remainder of the molecule is the constant region and is species-specific
 There are 5 different classes of antibody based on the structure of the constant
region
 IgG, IgA, IgM, IgD and IgE
56
Light chain
Arm (Fab)
Hinge
Stem (Fc)
Antigen-binding sites
Variable region
of heavy chain
Variable region
of light chain
Constant region
of light chain
Constant region
of heavy chain
Arm (Fab)
Hinge
Stem (Fc)
S
S
S
S
S S
S
S
Heavy chains
Figure 5 Basic antibody structure.
Antibody Actions
 Antibodies have the ability to bind to and eliminate foreign invaders too; the
techniques used include:
 1. Neutralization of the antigen by blocking its effects as a toxin or by
preventing its attachment to body cells
 2. Immobilize the antigen, and therefore also the bacteria on which it is
found, by attacking cilia/flagella
 3. Agglutinate & precipitate the antigens (and also, therefore, cells on which
they are found) by cross-linking them; this causes the clumping & precipitation
of the antigens/cells on which they are found
 4. Complement activation
 5. Enhancing phagocytosis through precipitation, complement activation or
opsonization (coating of antigen with a special substance to stimulate
phagocytosis)
Adhesin
proteins
Bacterium
Toxin Virus
Neutralization Agglutination
Pseudopod
of phagocyte
NK lymphocyte
Fcreceptor protein
Perforin allows granzyme
to enter, triggers apoptosis
and lysis
Antibody-dependent cellular
cytotoxicity (ADCC)
Bacteria die
Oxidation
Opsonization
Fcreceptor protein
Figure 6 Five functions of antibodies.
Role of the Complement System
 This is a defensive system of plasma proteins that attack and destroy microbes
specifically
 The system is activated by 2 different pathways to produce the same result
 1. Activated via inflammation: dilation of arterioles, release of histamine &
increased permeability of capillaries
 2. Activated by opsonization of antigen: a special protein binds to the
microbe, making it easier to phagocytize
 Activation of the complement system results in the cytolysis of the microbe: a
complex of several complement proteins can form holes in the microbe’s
plasma membrane, causing leakiness and cell rupture (which leads to cell
death)
Immunological Memory
 Primary immune response
 Occurs on the person’s first exposure to that antigen
 The immune response produced is steady, slow
 The immune response includes the formation of memory cells that may
remain for decades
 A secondary immune response occurs upon the second exposure to that
antigen
 In the immune memory there are 1000’s of memory cells that on the second
exposure will proliferate & differentiate into plasma cells & cytotoxic T-cells
specific to that antigen
 The antibody titer is a measure of the degree of immune memory (measures
the amount of serum antibody)
 Ideally, immune recognition & removal of the foreign cells/molecules occurs
so quickly that the person does not even become ill
Figure 19 The production of primary and secondary
antibody immune responses.
Self-Recognition & Immunological
Tolerance
 T-cells must learn to recognize self cells (based on self MHC molecules ) & NOT
react to self proteins
 This is referred to as self-recognition & immunological tolerance
 T-cells mature in the thymus
 Any T-cells that can’t accurately recognize self cells, or T-cells that react to
self cells, will be either destroyed by programmed cell death (apoptosis or
deletion), or inactivated (anergy) -- alive but unresponsive
 As a result of the above processes, only 1 in 100 emerges as an
immunocompetent T-cell
 B cells develop in the bone marrow in the same way
Figure 8. Clonal
deletion of
T cells.
Stem cell
(in red bone marrow)
Thymus
T cells
TCRs with
differently shaped
binding sites
MHC Epitope
Thymus
cells
Recognize
MHC?
Thymus
cells
No Yes
Receive survival
signal
Recognize
MHC-autoantigen?
Apoptosis
No Yes
Few Most
Repertoire of
immature Tc cells
Regulatory
T cell (Tr)
Apoptosis
3
4
2
1
Stem cell
(in red bone marrow)
B cells
Cell with
autoantigens
BCRs with
differently
shaped
binding sites
Cell with
autoantigens
Apoptosis
Blood vessel To spleen
1
2
3
4
Figure 9 Clonal deletion of B cells.
Aging and Immunity
 As we age, we are more susceptible to all types of infections and malignancies
 Our response to vaccines is decreased
 We produce more autoantibodies
 We experience reduced immune system function because:
 The T-cells become less responsive to antigens; this is due to the age-related
atrophy of the thymus and also to a decreased production of thymic hormones
 B cells become less responsive, and therefore production of antibodies is
slowed
TYPES OF IMMUNITY
 ACTIVE; this involves a person's OWN immune system being involved in
producing a response to Ag
 This lasts longer than passive immunity
 PASSIVE; This is a situation in which immunity is transferred from another
individual, whose own immune system was involved with Ag
 This provides immediate protection
 NATURAL
 Natural immunity results from unintentional exposure to antigen
 It is an everyday event (i.e. when you unintentionally are infected with a
disease)
 ARTIFICIAL
 This involves an intentional exposure to a pathogen or a vaccine which
produces intentional immunization and is used as a preventive measure
 Combinations of the above four categories are possible. For example, babies
receive collostrum from their mothers, which provides natural, passive
immunity; when you are immunized with an attenuated virus you will form an
artificial, active immunity to that pathogen.

Specific Immunity - Adaptive Immunity - Nursing

  • 1.
  • 2.
    Specific Resistance: Immunity It is mediated by the combined actions of both T and B lymphocytes  “THIRD LINE OF DEFENSE”  Specific immunity differs from nonspecific defense mechanisms with respect to:  Unresponsiveness to self - recognizes self cells vs. non-self cells/compounds  Memory - second and subsequent encounters produce an even more vigorous response than the first encounter with the same foreign cell/compound  Inducibility - the presence of specific, identifiable pathogens will induce/stimulate  Clonality - Upon activation, the cells involved in specific immunity reproduce identical “offspring”  Specificity - made against particular, recognizable, foreign molecules, cells, etc. response is directed against one and only one of these items
  • 3.
    The Role ofT and B Cells in Specific Immunity  T-cells mature in the thymus;  responsible for the cell-mediated immune response  effective against fungi, viruses, parasites, cancer, and tissue transplants  Killer T-cells  directly attack antigens = cytotoxic T-cells  Helper T-cells  co-stimulate T- and B-cells
  • 4.
     B-cells maturein the bone marrow  effective against extracellular pathogens such as bacteria  antibody-mediated immune response  plasma cells (activated B cells) that form antibodies and actively secrete them
  • 5.
    The Lymphatic System The lymphatic system drains lymph from all areas of the body and sends it back towards the heart to be returned to the blood circulatory system.  Once mature, the T and B cells migrate into the secondary lymphoid organs and lymphoid tissues such as lymph nodes, the spleen, tonsils, MALT (mucosa-associated lymphoid tissue),etc.  As the lymph moves through the lymphatic system, it is under constant surveillance for the presence of pathogens by the various cells of adaptive immunity
  • 6.
    Blood capillary From heart Tissue cell Intercellular fluid Lymph toheart via lymphatic vessels Gap in wall Valve Lymphatic capillary To heart Afferent lymphatic vessel Medulla Vein Artery Efferent lymphatic vessel Capsule Primary follicle Lymphatic nodule Valve (prevents backflow) Cortex Tonsils Cervical lymph node Lymphatic ducts Thymus gland Axillary lymph node Heart Breast lymphatics Spleen Abdominal lymph node Intestines Peyer's patches in intestinal wall Part of mucosa- associated lymphoid tissue (MALT) Appendix Red bone marrow Inguinal lymph node Lymphatic vessel
  • 7.
    What is anAntigen?  Molecules or bits of foreign material  entire microbes, parts of microbes, bacterial toxins, pollen, transplanted organs, incompatible blood cells  An antigen has:  Immunogenicity = the ability to provoke an immune response by stimulating the production of specific antibodies &/or specific T- cells  Reactivity = the ability to react to the cells or to the antibodies it caused to be formed
  • 8.
     If antigensget past the body’s nonspecific defenses where do they go to next?  They may:  Enter the bloodstream to be deposited in the spleen  Penetrate the skin & end up in the lymph nodes  Penetrate mucous membrane & lodge in the associated lymphoid tissue
  • 9.
    The Chemical Natureof Antigens/Epitopes  Antigens are generally large, complex molecules, usually proteins, though some lipids and carbohydrates can be antigens  If they have simple repeating subunits they are not usually antigenic  (I.e. plastics or metals in joint replacements)
  • 10.
     The smallpart of an antigen that actually elicits the immune response is called the epitope  It is also referred to as an antigenic determinant because it is the portion of the molecule that allows your immune system to determine that the molecule itself is an antigen.
  • 11.
  • 12.
  • 14.
    An antibody interactingwith the epitope on an antigen
  • 15.
    Sources of Antigens Antigens can originate exogenously, as parts of microbial cells’ structure (i.e. cell walls, flagella, pili, plasma membrane), or as chemicals secreted/released by a microbe (i.e. toxins)  Some antigens are referred to as being endogenous because their source is a microbe that reproduces inside the body’s own cells. Such microbes include viruses, protozoa, fungi and some bacteria.
  • 16.
     How doesthe immune system detect endogenous antigens?  The affected body cells must incorporate/add the antigen to the plasma membrane of that body cell so that it can be ‘seen’ or detected by cells of adaptive immunity  Finally, some antigens are referred to as being autoantigens because they are molecules belonging to ‘self’. Normally, the immune system learns tolerance to these cells and ‘ignores’ them
  • 17.
    Diversity of AntigenReceptors  The immune system can recognize and respond to a billion different epitopes -- even artificially made molecules  An explanation for the great diversity of receptors is that this diversity is produced by the genetic recombination of a few hundred small gene segments
  • 18.
     Each Bor T-cell, by the time it has matured, has its own unique set of gene segments (produced through somatic recombination) that codes for its own unique antigen receptor, located in the B or T-cell’s plasma membrane  Therefore, we have an enormously diverse population of immune cells ready to respond to foreign antigens
  • 19.
    Major Histocompatibility Complex(MHC) Antigens  They are a family of membrane proteins  All of our cells have unique surface markers (1000s of molecules)  These integral membrane proteins are called HLA (for human leukocyte antigen) antigens, or MHC-antigens/markers
  • 20.
     While theseproteins are recognized as ‘self’ in OUR bodies, in another person, with different MHC-markers, these same molecules would stimulate a specific immune response  Hence, they are usually referred to as MHC-antigens  Reference to them as ‘markers’ in these notes is done to avoid confusion with use of the word ‘antigen’ as a reference to foreign molecules (i.e. from bacteria, virus, etc.)
  • 21.
     The MHCmarkers allow our bodies to identify ‘self’ versus ‘non-self’ based on the precise nature of the MHC molecules on the cell surfaces  MHC-I markers are built into the cell membrane of all cells except red blood cells  Therefore, they are often referred to as being present on all nucleated cells in our bodies  MHC-II markers are seen only on the membrane of specialized antigen- presenting cells (such as macrophages, B cells, and thymus cells)  When antigen-presenting cells (APCs) (macrophages or B cells) ingest foreign proteins through phagocytosis, they will display them as part of (i.e. attached to) their MHC-II markers
  • 22.
     This seriesof proteins is coded for genetically and involves a large number of alleles  Only identical twins carry the same set of MHCs  MHC markers are important in tissue transplantation since they identify ‘self’ versus ‘foreign’ tissue types to the recipient’s immune system  MHC-I marker molecules also help cells display antigens from intracellular pathogens (i.e. endogenous antigens)
  • 23.
    Polypeptide is catabolized. Epitopes MHC Iprotein in membrane of endoplasmic reticulum Lumen of endoplasmic reticulum Epitopes are loaded onto complementary MHC I proteins in the ER. MHC I protein– epitope complex Golgi bodies package MHC I protein–epitope complexes into vesicles. MHC I protein– epitope complexes on cell surface Cytoplasmic membrane MHC I protein–epitope complexes are displayed on cytoplasmic membranes of all nucleated cells. 5 4 3 2 1 Vesicles fuse with cytoplasmic membrane. Figure 12 The processing of endogenous antigens.
  • 25.
    Phagocytosis by APC Exogenous pathogen with antigens MHCII protein in membrane of vesicle Epitopes in phagolysosome MHC II protein– epitope complex Vesicles fuse and epitopes bind to complementary MHC II molecules. Vesicle fuses with cytoplasmic membrane. MHC II protein– epitope complexes on cell surface Cytoplasmic membrane MHC II protein–epitope complexes are displayed on cytoplasmic membranes of antigen- presenting cell. 1 2 3 4 Figure 13 The processing of exogenous antigens.
  • 26.
     MHC-II antigensthen bind to receptors on helper T cells  The helper T cells are now activated by this interaction and will go on to activate cytotoxic T cells and B cells (the latter of which will produce antibodies to the foreign protein that was originally displayed)
  • 27.
    Cell-Mediated Immunity  Beginswith the activation of a T-cell by a specific antigen; recognition of that antigen is the FIRST signal in the T-cell activation process  The T-cell will bind to the recognized antigen and only then will receive a SECOND signal; this signal is the co-stimulation of the T-cell by chemicals such as cytokines or by the plasma membrane molecules on both the T-cell and the antigen-presenting cell
  • 28.
     Once theT-cell has received TWO signals it is activated  The T-cell then proliferates (divides) and differentiates into identical effector cells (a clone) that are all capable of recognizing the SAME antigen
  • 29.
     The activation,proliferation and differentiation of the various types of T-cells occurs in the secondary lymphatic organs such as the lymph nodes  The result is the production of a population of T-cells capable of an immune attack against THAT antigen  The elimination of the intruder occurs via a direct attack on the intruder by the T-cells
  • 30.
    Types of T-Cells Helper T-cells; TH; also called CD4+ cells because they display CD4 protein  Cytotoxic T-cells; TC; also called CD8+ cells because they display CD8 protein  Memory T-cells; of both of above kinds; long-term ‘memory’ of encountered antigens that permits rapid, strong second response to that antigen
  • 31.
    Helper T-cells  Recognizeantigen fragments bound to the MHC-II molecules in the plasma membranes of APCs  The MCH-II molecules also bind to and ‘activate’ the TH cells
  • 32.
     Co-stimulation occursand leads to the TH-cell’s production of cytokines such as interleukin-2 (which stimulates further T-cell differentiation and further release of IL-2)  Activated T-cell proliferates & differentiates into a population (clone) of active TH cells and long-lived memory TH cells
  • 33.
    Figure 14 Activationof a clone of cytotoxic T (Tc) cells. Antigen presentation MHC II Epitope TCR Th cell Th differentiation Th1 cell IL-2R IL-2 IL-2R IL-12 DC IL-2 Active Tc cells MHC I Inactive Tc cell IL-2 receptor (IL-2R) Clonal expansion Memory T cell Self-stimulation IL-2 IL-2 Dendritic cell MHC I CD8 Epitope TCR Tc cell Immunological synapse Active Tc cells 1 2 3 4
  • 34.
     The overallfunction of TH cells is to co-stimulate all other lymphocytes, including natural killer cells by:  Secretion of cytokines (i.e. interleukin-2)  The use of cytokines for the co-stimulation of more TH cells
  • 35.
     The co-stimulationrole of cytokines is an autocrine function in that the cytokine co-stimulates the TH cell that secreted it, causing the TH cell to proliferate and secrete even more cytokines such as interleukin (this is a positive feedback effect that stimulates the formation of many more active helper T-cells)
  • 36.
    Cytotoxic T-cells  Knownas T8 or Tc or killer T-cells  Recognize antigen fragments that are bound to MHC-I molecules; these would be found on:  Cells infected with a virus  Tumor cells  Tissue transplants of non-matching tissue type
  • 37.
     Co-stimulation ofcytotoxic T-cells is required for them to be active, and this is accomplished by the presence of cytokine chemicals that are produced by the helper T-cell population
  • 38.
     Maximal activationof cytotoxic T-cells occurs when an antigen is presented in association with BOTH MHC-I and MHC-II molecules  The TC cell then proliferates & differentiates into a population (clone) of active Tc cells and memory Tc cells  This step occurs in the secondary lymphatic organs such as the lymph nodes
  • 39.
    Memory T-cells  MemoryT-cells are T-cells from a clone that did not turn into either active TH or active TC cells during a cell-mediated response  These cells are available for swift response if a second exposure to the same antigen should occur  These cells ‘remember’ which antigen to react to, therefore are termed ‘memory’ T-cells
  • 40.
    Elimination of Invaders Activated TC cells migrate to the site of infection or tumor formation  These cells recognize the specific antigen, attach to it & attack  They ultimately kill the cell to which the antigen is bound by:
  • 41.
     1. Secretionof granules containing perforin that punches holes in the target-cell which will then permit the entry of a cytotoxin known as granzyme whose action is to induce apoptosis in the target cell  2. Secretion of a chemical called lymphotoxin that activates enzymes in the target-cell, causing its DNA to fragment; target cell dies
  • 42.
     3. Secretionof gamma-interferon to activate phagocytic cells, which engulf target cell and digest it  Thus, foreign cells, cells infected with viruses or cells that have turned cancerous, will be killed
  • 43.
    Active cytotoxic T (Tc) cell TCR Viralepitope MHC I protein Virally infected cell Intracellular virus CD8 Figure 15a. A cell-mediated immune response.
  • 44.
    44 Tc cell Perforin Granzyme Perforin complex(pore) Granzymes activate apoptotic enzymes Inactive apoptotic enzymes Active enzymes induce apoptosis Virally infected cell Tc cell CD95L CD95 Enzymatic portion of CD95 becomes active Inactive apoptotic enzymes Active enzymes induceapoptosis Virally infected cell Figure 15b-c A cell-mediated immune response.
  • 45.
    Immunological Surveillance  Acancerous cell displays weird/unusual surface antigens (tumor antigens) that are rarely, if ever, found on normal cells  Surveillance = ability for the immune system to find, recognize & destroy those cells that are displaying tumor antigens
  • 46.
     Immunological surveillanceis performed by cytotoxic T-cells, macrophages & natural killer cells  It is especially effective at finding tumors that are caused by viruses  Transplant patients taking immunosuppressive drugs are at the greatest risk of contracting viral-induced cancers
  • 47.
    Graft Rejection  Aftera tissue or organ transplant, the immune system may produce both a cell-mediated and an antibody-mediated immune response  This response constitutes graft rejection
  • 48.
     Having aclose match of MHC antigens will result in a weaker graft rejection response  The chance of a graft rejection can also be reduced by the use of immunosuppressive drugs (such as cyclosporine); these drugs Inhibit the secretion of interleukin-2 by helper T-cells  However, the drugs have little effect on B cells so the patient maintains some resistance
  • 49.
    Antibody-Mediated Immunity  Ourbodies contain millions of different B cells that can recognize different antigens and respond to them  B cells sit still and let antigens be brought to them  The B cells are specifically located in the lymph nodes, the spleen or in Peyer’s Patches (in the GI system)
  • 50.
     Once activated,B-cells differentiate into plasma cells that actively secrete antibodies  The antibodies circulate in the lymph and the blood  The antibody combines with an epitope on the antigen, similarly to a key fitting a specific lock
  • 51.
     B cellreceptors bind to an antigen – the response will be even more intense if the antigen is already on an APC  A helper T-cell costimulates the B cell  The stimulated B-cell then undergoes rapid cell division and differentiation to produce:  1. Long-lived memory cells
  • 52.
     2. Aclone of plasma cells (which will actively secrete antibodies against the antigen)  The plasma cells will produce antibodies at a rate of 2000 Ab molecules/sec for 4-5 days  The plasma cells secrete only one kind of Ab ( the one that is specific to the original Ag)  The Ab enters the blood/lymph circulation to attack the antigen
  • 53.
    Repertoire of Thcells (CD4 cells) CD4 TCRs APC presents antigen to Th cells for Th activation and cloning. APC Th cell TCR Epitope MHC II CD4 CD28 CD80 (or CD86) APC Th cell clones Th cell differentiates into Th2 cell. CCR3 CCR4 Th2 cell IL-4 MHC II proteins Repertoire of B cells Th2 cell TCR Epitope MHC II CD40 CD40L CD4 Th2 cell activates B cell. Clone of plasma cells Antibodies Memory B cells Th2 cell B cell 1 2 3 4 IL-4 Figure 18 A T-dependent antibody immune response.
  • 54.
    Antibody Structure  Antibodiesare glycoproteins that are also called immunoglobulins  They contain 4 polypeptide chains -- 2 heavy & 2 light chains  There is a hinged midregion that lets the Ab assume either a T or a Y shape
  • 55.
     The tipsare the variable regions – these form the Ag-binding sites  The remainder of the molecule is the constant region and is species-specific  There are 5 different classes of antibody based on the structure of the constant region  IgG, IgA, IgM, IgD and IgE
  • 56.
    56 Light chain Arm (Fab) Hinge Stem(Fc) Antigen-binding sites Variable region of heavy chain Variable region of light chain Constant region of light chain Constant region of heavy chain Arm (Fab) Hinge Stem (Fc) S S S S S S S S Heavy chains Figure 5 Basic antibody structure.
  • 57.
    Antibody Actions  Antibodieshave the ability to bind to and eliminate foreign invaders too; the techniques used include:  1. Neutralization of the antigen by blocking its effects as a toxin or by preventing its attachment to body cells  2. Immobilize the antigen, and therefore also the bacteria on which it is found, by attacking cilia/flagella
  • 58.
     3. Agglutinate& precipitate the antigens (and also, therefore, cells on which they are found) by cross-linking them; this causes the clumping & precipitation of the antigens/cells on which they are found  4. Complement activation  5. Enhancing phagocytosis through precipitation, complement activation or opsonization (coating of antigen with a special substance to stimulate phagocytosis)
  • 59.
    Adhesin proteins Bacterium Toxin Virus Neutralization Agglutination Pseudopod ofphagocyte NK lymphocyte Fcreceptor protein Perforin allows granzyme to enter, triggers apoptosis and lysis Antibody-dependent cellular cytotoxicity (ADCC) Bacteria die Oxidation Opsonization Fcreceptor protein Figure 6 Five functions of antibodies.
  • 60.
    Role of theComplement System  This is a defensive system of plasma proteins that attack and destroy microbes specifically  The system is activated by 2 different pathways to produce the same result  1. Activated via inflammation: dilation of arterioles, release of histamine & increased permeability of capillaries
  • 61.
     2. Activatedby opsonization of antigen: a special protein binds to the microbe, making it easier to phagocytize  Activation of the complement system results in the cytolysis of the microbe: a complex of several complement proteins can form holes in the microbe’s plasma membrane, causing leakiness and cell rupture (which leads to cell death)
  • 63.
    Immunological Memory  Primaryimmune response  Occurs on the person’s first exposure to that antigen  The immune response produced is steady, slow  The immune response includes the formation of memory cells that may remain for decades
  • 64.
     A secondaryimmune response occurs upon the second exposure to that antigen  In the immune memory there are 1000’s of memory cells that on the second exposure will proliferate & differentiate into plasma cells & cytotoxic T-cells specific to that antigen
  • 65.
     The antibodytiter is a measure of the degree of immune memory (measures the amount of serum antibody)  Ideally, immune recognition & removal of the foreign cells/molecules occurs so quickly that the person does not even become ill
  • 66.
    Figure 19 Theproduction of primary and secondary antibody immune responses.
  • 67.
    Self-Recognition & Immunological Tolerance T-cells must learn to recognize self cells (based on self MHC molecules ) & NOT react to self proteins  This is referred to as self-recognition & immunological tolerance
  • 68.
     T-cells maturein the thymus  Any T-cells that can’t accurately recognize self cells, or T-cells that react to self cells, will be either destroyed by programmed cell death (apoptosis or deletion), or inactivated (anergy) -- alive but unresponsive  As a result of the above processes, only 1 in 100 emerges as an immunocompetent T-cell  B cells develop in the bone marrow in the same way
  • 69.
    Figure 8. Clonal deletionof T cells. Stem cell (in red bone marrow) Thymus T cells TCRs with differently shaped binding sites MHC Epitope Thymus cells Recognize MHC? Thymus cells No Yes Receive survival signal Recognize MHC-autoantigen? Apoptosis No Yes Few Most Repertoire of immature Tc cells Regulatory T cell (Tr) Apoptosis 3 4 2 1
  • 70.
    Stem cell (in redbone marrow) B cells Cell with autoantigens BCRs with differently shaped binding sites Cell with autoantigens Apoptosis Blood vessel To spleen 1 2 3 4 Figure 9 Clonal deletion of B cells.
  • 71.
    Aging and Immunity As we age, we are more susceptible to all types of infections and malignancies  Our response to vaccines is decreased  We produce more autoantibodies
  • 72.
     We experiencereduced immune system function because:  The T-cells become less responsive to antigens; this is due to the age-related atrophy of the thymus and also to a decreased production of thymic hormones  B cells become less responsive, and therefore production of antibodies is slowed
  • 73.
    TYPES OF IMMUNITY ACTIVE; this involves a person's OWN immune system being involved in producing a response to Ag  This lasts longer than passive immunity  PASSIVE; This is a situation in which immunity is transferred from another individual, whose own immune system was involved with Ag  This provides immediate protection
  • 74.
     NATURAL  Naturalimmunity results from unintentional exposure to antigen  It is an everyday event (i.e. when you unintentionally are infected with a disease)  ARTIFICIAL  This involves an intentional exposure to a pathogen or a vaccine which produces intentional immunization and is used as a preventive measure
  • 75.
     Combinations ofthe above four categories are possible. For example, babies receive collostrum from their mothers, which provides natural, passive immunity; when you are immunized with an attenuated virus you will form an artificial, active immunity to that pathogen.